Catalent, Novo Nordisk

Novo Holdings completes $16.5 billion takeover of Catalent
Novo Holdings has completed its $16.5 billion acquisition of Catalent, the contract drug manufacturer said on Wednesday, days after the companies disclosed that all regulatory conditions to close the deal were fulfilled.
Novo Holdings completes Catalent acquisition for $16.5bn
Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European Commission (EC) gave its approval in early December 2024. Catalent's common stock will no longer be listed on the New York Stock Exchange.
Novo completes $16.5bn takeover of Catalent
Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.
Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent
Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the Danish drugmaker looks to boost supplies of its widely popular weight-loss drug Wegovy.
Novo Holdings set to close $16.5B Catalent buy in 'coming days' after deal clears antitrust hurdles
After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to unwrap its $16.5 billion present just in time for the holidays.
Catalent Acquired by Novo Holdings in $16.5 Billion Deal
The latest announcement is out from Catalent ( (CTLT) ).
Novo Completes $16.5 Billion Acquisition of Catalent
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/16.DQzHZcKY.js
The Global Legal Post41m
Skadden, Goodwin, Davis Polk act as Novo closes $16.5bn Catalent deal
The all-cash deal has involved Novo Holdings acquiring Catalent for $16.5bn, including debt. It will then sell three of ...
STAT4d
Pharmalittle: We’re reading about Novo Holdings proceeding with Catalent deal, Sanofi threatened with sanctions, and more
Novo Holdings can proceed with its planned $16.5 billion acquisition of Catalent after U.S. regulators declined to challenge ...
This industrials company is joining the S&P 500 soon
Heating and air conditioning equipment maker Lennox International Inc. is replacing contract drug maker Catalent Inc. in the ...
MM&M3d
Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle
Novo Holdings is on track to acquire Catalent, a global contract development and manufacturing organization, in a $16.5 ...
Lennox to replace Catalent in S&P 500 at open on 12/23
Novo Holdings (NVO) has acquired Catalent (CTLT) in a deal that closed on December 18.Pick the best stocks and maximize your portfolio:Discover ...
WFIU3d
Danish pharma giant cleared to buy Catalent
Novo Holdings, parent company of the pharmaceutical giant Novo Nordisk, is spending $16.5 billion on the acquisition. The ...
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) announced plans to invest approximately $1.20 billion (8.5 billion ...
Health Care Roundup: Market Talk
Find insight on Novo Holdings, Malaysian glove sector and more in the latest Market Talks covering health care.